A Retrospective Analysis of the Clinical Studies of a Drug "Flakozid" in the Treatment of Diseases of the Hepatobiliary System
Introduction. The medicine "Flakozid" with hepatoprotective effect has been developed at the VILAR. The drug is presented in dosage form-tablets of 0.1 g for oral drug administrationAim. To analyze the clinical efficacy and safety of "Flakozid" therapy according to clinical labor...
Main Authors: | V. V. Bortnikova, V. V. Karabaeva, L. V. Krepkova, P. G. Mizina, A. N. Babenko, N. S. Mikheeva, O. N. Karabaeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2021-08-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/880 |
Similar Items
-
Retrospective Analysis of Experimental and Clinical Studies of Flakozid in Viral Hepatitis
by: V. V. Karabaeva, et al.
Published: (2021-11-01) -
CHARACTERISTICS OF LIPID STORAGE DISORDERS IN CHILDREN WITH HEPATOBILIARY PATHOLOGY
by: А. E. Lavrova, et al.
Published: (2014-03-01) -
Staging in the treatment of chronic calculous cholecystitis, complicated by choledocholithiasis
by: Alexander V. Smirnov, et al.
Published: (2024-12-01) -
Roflumilast, ursodeoxycholic acid and nucleinate efficiency in patients with chronic obstructive pulmonary disease with accompanying chronic non-stone cholecystitis.
by: Dudka T.V., et al.
Published: (2014-11-01) -
A case of Vagococcus fluvialis isolated from the bile of a patient with calculous cholecystitis
by: Dan Zhang, et al.
Published: (2023-10-01)